Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
News
Festakt zur Einweihung des FAU NeW
Vortrag bei Akademie gemeinnütziger Wissenschaften zu Erfurt
Book chapter “Sustainability in Drug and Nanoparticle Processing” published
2. Verbundmeeting TEL-Drug Delivery
DPhG Vortrag “Hype or hope? Sinn und Unsinn von Nahrungsergänzungsmitteln” Do., 29.06.2023
3D screen printing technology enables fabrication of oral drug dosage forms with freely tailorable release profiles
DPhG Vortrag, 25.05.2023, “ Analyse von Genregulationsprozessen auf Einzelmolekülebene”, Prof. Dr. Bernd Knöll
Großes Interesse an Antrittsvorlesungen
Neues FAU-Forschungszentrum Neue Wirkstoffe nimmt Arbeit auf
FAU-Team forscht an einfacher Covid-19-Impfung mit mRNA-Wirkstoff
Contact - Secretariat
Petra Neubarth, VA
Sekretärin
Cauerstraße 4 (Haus 6)
91058 Erlangen
Cauerstraße 4 (Haus 6)
91058 Erlangen
- Phone number: +49 9131 85-29551
- Email: petra.neubarth@fau.de
- Website: http://www.pharmtech.uni-erlangen.de